In contrast, Tbx21−/− bone marrow chimeric mice, which showed a profound reduction in IFNγ-producing Th1 T-cells compared with WT controls, showed a comparable CLL progression to control mice [17]. This evidence concerns the gene IFNG and B-cell chronic lymphocytic leukemia.